Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
about
Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial SurgeonsAntiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw.Existing data sources for clinical epidemiology: Scandinavian Cohort for osteonecrosis of the jaw - work in progress and challenges.Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effectBisphosphonates and osteonecrosis: an open matter.Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse modelOsteonecrosis of the jaw (ONJ): diagnosis and management in 2015.Sinusitis and oroantral fistula in patients with bisphosphonate-associated necrosis of the maxilla.Intravenous bisphosphonate-related osteonecrosis of the jaws: influence of coadjuvant antineoplastic treatment and study of buccodental condition.Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice.Pathophysiology of Osteonecrosis of the Jaws.Treatment of bisphosphonate related osteonecrosis following root canal therapy at the 1-year follow-up: report of two cases.Radiographic Findings in Patients with Medication-Related Osteonecrosis of the Jaw.A current update on osteonecrosis of the jaw and bisphosphonates.Non-exposed bisphosphonate-related osteonecrosis of the jaw: a critical assessment of current definition, staging, and treatment guidelines.Bisphosphonates and their clinical implications in endodontic therapy.The phosphorous necrosis of the jaws and what can we learn from the past: a comparison of "phossy" and "bisphossy" jaw.Animal models for bisphosphonate-related osteonecrosis of the jaws--an appraisal.Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease.Important aspects concerning alendronate-related osteonecrosis of the jaws: a literature review.Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents.Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: personal experience and review of the literatureResponse to comments on "diagnosis and management of osteoporosis of the jaw: a systematic review and international consensus".Comments on "diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus".Exposed necrotic bone in 183 patients with bisphosphonate-related osteonecrosis of the jaw: Associated clinical characteristics.Denosumab-related osteonecrosis of the jaw in a patient with bone metastases of prostate cancer: A case report and literature review.Concept, diagnosis and classification of bisphosphonate-associated osteonecrosis of the jaws. A review of the literature.Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study.Hyperbaric oxygen therapy and osteonecrosis.Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology.Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.Adjudication of osteonecrosis of the jaw in phase III randomized controlled trials of denosumab: a systematic review.Multiple myeloma vs. breast cancer patients with bisphosphonates-related osteonecrosis of the jaws: a comparative analysis of response to treatment and predictors of outcome.Medication-related osteonecrosis of the jaw. Introduction of a new modified experimental model.Stage 0 osteonecrosis of the jaw in a patient on denosumab.Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ).Histological findings on jaw osteonecrosis associated with bisphosphonates (BONJ) or with radiotherapy (ORN) in humans.Bisphosphonates-related osteonecrosis of the jaws: medicolegal issues.Does CBCT alter the diagnostic thinking efficacy, management and prognosis of patients with suspected Stage 0 medication-related osteonecrosis of the jaws?A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer.
P2860
Q26771715-72DB39E3-C202-49F6-AE79-23B38B803974Q30239854-84212E03-C579-4A3E-BB80-B739A4775AA4Q30888611-75B81B96-34E4-4258-8ADA-C3BFBE7FC0C2Q34322430-4087A642-D63D-4FA2-9837-0C2746772CB8Q34536480-4FC10CEB-AEA7-4A0A-9C97-D68445C82013Q35764778-89D97EC3-3627-4491-BEE5-FBBFF63767A4Q35818022-65C74B93-72CB-4763-977E-601528B04404Q36433392-494811D9-4182-4C42-BCB9-DAD1B4BAD460Q36733315-DE643612-7A11-452B-A45C-4ADF75D52503Q36945036-61CF2EF5-853A-43AD-BA8C-647296404B20Q37006852-DD542FD2-101A-40CF-9FA3-48194814079EQ37388377-E1B317FD-2EC9-436A-BEA6-CB49C8973545Q37703472-CBE89DB8-DB62-480E-86F6-CC609A5BE6B1Q37992647-FB619290-9C63-4E6A-B79E-E694CECE59E8Q37993918-CD7C7685-6937-4A0D-B251-C143F4350AD8Q38058563-DDC5AE96-7CB1-4AA7-B0BD-AC173FEA63E6Q38070103-E14321F8-F0B0-4C0B-8A29-7D73581D8FCDQ38076462-6865F2A5-1FA7-4D6A-8AF6-AEBA62C30F1CQ38104993-03C4BABE-6C3E-44ED-BFD7-5BBC503E4CD8Q38164436-5617A7F9-7B70-4575-B00D-0486BBAB1DEEQ38184580-846D271D-D3B8-4459-BC55-E17627F20F9DQ38228320-FFE61B09-4DDE-4BAB-9F64-AEA23D21AD1DQ38457969-7D0576E5-12C7-44EC-A793-E2BEA708785DQ38490996-57CED0BC-99CD-4886-8B68-B671D5C403DEQ38624057-A40E918C-D431-4159-BE77-24D055E88963Q38660112-47C59FD5-FE81-4573-B123-824F798FE661Q38716842-B6034DA8-AF93-4F0E-9939-E007419CD69BQ38776007-6AEB24B2-0884-4D7B-B531-F9BB4D235D2EQ38803408-1B7CEA31-5B02-4DCF-91CB-EAB8FBC7E49AQ38807483-E7908122-47BA-491E-B5D7-5AB4F1561323Q38831851-2823E3DF-DBB8-4F4B-AE02-35104C3D597EQ39130990-180AA609-CD7D-49F1-BDAD-F6E4188BF7A8Q39686090-CADCA5FD-9AC5-4910-9BF0-7BE2E84BB9B2Q39700905-DDB2D21E-F5A0-42C1-9052-141CCBE9228AQ40293083-876C6A5A-50A0-4B6C-9B28-D110B30CCBF6Q42325555-C7081AB5-1BAF-4FAE-BE05-722DCF45578EQ43575598-F2F90F19-D63D-4FF9-87A4-1950CED18EA9Q46094334-CA52E9CF-7634-41A3-9AA0-5FA5DDD18016Q46146438-34F7C50B-A8C1-4046-883A-DEF6A81C2714Q47252665-6A06BC59-1823-41EC-97F9-12FDA24DC19A
P2860
Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
@en
Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
@nl
type
label
Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
@en
Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
@nl
prefLabel
Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
@en
Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
@nl
P2093
P50
P1476
Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
@en
P2093
Anna Musciotto
Francesco D'Aiuto
Naom Yarom
Paolo Vescovi
Stefano Fedele
Stephen R Porter
Tony S Lazarovici
P304
P356
10.1016/J.AMJMED.2010.04.033
P407
P577
2010-09-28T00:00:00Z